Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Turing Medical Technologies, Inc.
About
  2. Companies
  3. Turing Medical Technologies, Inc.
  4. Software
  5. Turing Medical - Personalized Adaptive ...

Turing Medical - Personalized Adaptive Cortical Electro-Stimulation (PACE) for Neuromodulation

SHARE
PACE represents a transformative advance in neuromodulation therapies by employing Personalized Adaptive Cortical Electro-Stimulation. This innovative approach is designed to deliver targeted therapies through the Bullsai platform, renowned for its precise mapping capabilities. PACE is currently under clinical development to treat conditions such as treatment-resistant depression, with further applications for a variety of neuropsychiatric and pain disorders anticipated. The technology builds on the FDA 510(k) cleared Bullsai platform which constructs patient-specific brain maps, optimizing neuromodulation targeting through adaptive algorithms that adjust stimuli in real-time. This closed-loop system enhances efficacy and safety, tailoring therapy to individual brain circuits. PACE stands out with its minimally invasive delivery method, offering a durable neurotherapy solution that aligns FDA-cleared mapping technology with novel therapeutic methodologies to advance personalized neural treatments.
Most popular related searches
brain mapping
neuromodulation therapy
clinical development
neuromodulation
brain circuit
depression
brain activity
depression treatment
implant
implant surfaces

Personalized Adaptive Cortical Electro-Stimulation redefines how neuromodulation therapies are delivered.

This innovative approach integrates the precise targeting capabilities of the Bullsai platform with a novel minimally invasive delivery approach therapy designed to provide sustainable relief. Leveraging our FDA 510(k) cleared Bullsai technology, PACE creates individualized treatment protocols tailored to each patient’s unique brain circuitry.

PACE is currently in clinical development for treatment-resistant depression, with future applications in other neuropsychiatric and pain disorders.

Leveraging Bullsai and a novel minimally-invasive delivery approach

Pace builds on our FDA 510(k) cleared Bullsai Identify platform that creates detailed functional brain maps unique to each patient. These maps guide personalized, precise targeting of neuromodulation, while our adaptive algorithms interpret real-time feedback to optimize stimulation parameters. This closed-loop approach ensures therapy is always precisely tailored to the individual patient’s brain.

 

Revolutionary, minimally invasive delivery approach designed to deliver durable results.

  • Personalized Targets: PACE uses patient-specific precision functional brain mapping to identify optimal stimulation sites with millimeter accuracy.
  • Adaptive Stimulation: Unlike conventional fixed stimulation, PACE adjusts therapy parameters to fit your brain.
  • Minimally Invasive: PACE delivers targeted therapy to the brain’s surface, without implanting depth electrodes.
  • Sustained Benefits: Designed to provide long-lasting symptom relief for treatement-resistant depression.